adr_usa_0459|BVXV|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
adr_usa_0459|BVXV|1|BiondVax Pharmaceuticals Ltd Total Current Assets (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Cash and Short Term Investments (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Inventories (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Net PP&E (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Goodwill and Intangibles (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Total Liabilities (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Total Current Liabilities (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Total Long Term Liabilities (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Total Deposits (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Book Value (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Retained Earnings (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Treasury Stock (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd EV to Revenues|BiondVax Pharmaceuticals Ltd EV to Earnings|BiondVax Pharmaceuticals Ltd EV to Free Cash Flow|BiondVax Pharmaceuticals Ltd EV to Assets (Quarterly)|BiondVax Pharmaceuticals Ltd PS Ratio|BiondVax Pharmaceuticals Ltd PE Ratio|BiondVax Pharmaceuticals Ltd Price to Book Value|BiondVax Pharmaceuticals Ltd PEG Ratio|BiondVax Pharmaceuticals Ltd Debt to Equity Ratio|BiondVax Pharmaceuticals Ltd Dividend Yield|BiondVax Pharmaceuticals Ltd Shareholder Yield (TTM)|BiondVax Pharmaceuticals Ltd Percent of Shares Outstanding Short|BiondVax Pharmaceuticals Ltd Total Receivables (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Total Payables (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Total Capital Stock (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Return on Invested Capital|BiondVax Pharmaceuticals Ltd Quality Ratio Score|BiondVax Pharmaceuticals Ltd Momentum Score|BiondVax Pharmaceuticals Ltd Beta (1Y)|BiondVax Pharmaceuticals Ltd Sustainable Growth Rate (TTM)|BiondVax Pharmaceuticals Ltd Institutional Investor Ownership Percentage|BiondVax Pharmaceuticals Ltd Average Diluted Shares Outstanding (Quarterly)|BiondVax Pharmaceuticals Ltd Total Employees (Annual)|BiondVax Pharmaceuticals Ltd EPS Diluted (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Shares Outstanding|BiondVax Pharmaceuticals Ltd Repurchase of Capital Stock (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Ordinary Shares Number (Quarterly)|BiondVax Pharmaceuticals Ltd Payout Ratio|BiondVax Pharmaceuticals Ltd Quick Ratio (Quarterly)|BiondVax Pharmaceuticals Ltd Normalized Diluted EPS (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Stock Buybacks (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Effective Tax Rate (TTM)|BiondVax Pharmaceuticals Ltd Return on Equity|BiondVax Pharmaceuticals Ltd Net Income (TTM) (USD)|BiondVax Pharmaceuticals Ltd Revenue (TTM) (USD)|BiondVax Pharmaceuticals Ltd Dividend Per Share (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Revenue (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Gross Profit (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd SG&A Expense (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Pre-Tax Income (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Net Income (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Net Interest Income (Quarterly) (USD)|BiondVax Pharmaceuticals Ltd Price (USD)|BiondVax Pharmaceuticals Ltd Total Return Price (USD)|BiondVax Pharmaceuticals Ltd Enterprise Value (USD)|BiondVax Pharmaceuticals Ltd 30-Day Average Daily Volume|BiondVax Pharmaceuticals Ltd 1 Year Price Returns (Daily)||
adr_usa_0459|BVXV|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
adr_usa_0459|BVXV|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|yearly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly||
adr_usa_0459|BVXV|5|98.875|98.875|0|98.875|0|98.875|98.875|98.875|0|98.875|98.875|0|0|0|7.14028776978|0|0|0|7.13513513514|0|0|1.52927580894|0|15.2325581395|98.875|98.875|98.875|0|0|33.0425531915|30.4423076923|0|0|91.2962962963|339|91.2962962963|56.3529411765|0|91.3043478261|0|0|91.2962962963|91.3|0|0|91.3333333333|0|0|0|91.25|91.2962962963|91.2962962963|91.2962962963|91.2962962963|7.14028776978|7.14028776978|7.14028776978|7.11721611722|7.13215859031||
adr_usa_0459|BVXV|6|24|24|0|24|0|24|24|24|0|24|24|0|0|0|278|0|0|0|185|0|0|1298|0|129|24|24|24|0|0|47|52|0|0|27|5|27|34|0|23|0|0|27|20|0|0|24|0|0|0|4|27|27|27|27|278|278|278|273|227||
adr_usa_0459|BVXV|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
adr_usa_0459|BVXV|201309||||||||||||||||||||||||||||||||||3.2674||-0.1671||||||-0.1671||||||||0|0.1485|-0.5459|-0.5459|-0.0031|||||||
adr_usa_0459|BVXV|201312|5.8647|5.7238||0.946||0.529|0.5132|0.0158||6.9074|-17.7737||||||||||||||0.1328|0.349|0|||||||3.2674||-0.1886||||||-0.1886|||||||||0.1279|-0.6164|-0.6164|-0.1003|||||||
adr_usa_0459|BVXV|201403||||||||||||||||||||||||||||||||||3.2674||-0.1725||||||-0.1725||||||||0|0.1585|-0.5637|-0.5637|0.0152|||||||
adr_usa_0459|BVXV|201406||||||||||||||||||||||||||||||||||3.2674||-0.1966||||||-0.1966|0|||-2.3685||||0|0.1659|-0.6425|-0.6425|-0.0119|||||||
adr_usa_0459|BVXV|201409|3.9946|3.9222||0.7594||0.4119|0.3953|0.0166||4.9769|-18.4104||||||||||||||0.0723|0.3953|0|||||||3.2674||-0.1569|||135.0974|||-0.1569||||-2.3352||||0|0.1598|-0.5126|-0.5126|0.0456|||||||
adr_usa_0459|BVXV|201412|3.2654|2.9877||0.6778||0.4818|0.4658|0.0159||4.2619|-17.853||||||||||||||0.268|0.2659|0|||||||3.2674||-0.1419|||135.0974|||-0.1419|0|||-2.1825|||||0.2164|-0.4637|-0.4637|0.0538|||||||
adr_usa_0459|BVXV|201503|2.6329|2.3789||0.6268||0.4291|0.413|0.0162||3.708|-18.0313||||-5.6956||||3.93|||0||0.2752|0.254|0.413|0|||||||2.8174|16|-0.168|3.2674||135.0974|||-0.168|0|||-2.0921|||||0.165|-0.4733|-0.4733|-0.0107|4.46|4.46|12.1937||||
adr_usa_0459|BVXV|201506|10.8009|10.5986||0.6244||2.5155|0.3879|2.1276||9.5284|-20.2975||||-2.5945||||1.7546|||0||0.8832|0.2023|0.3879|0|||||||2.4071||-0.5172|3.3774||135.0974|||-0.5172|-7.0661|||-2.7948|||||0.1552|-1.3453|-1.3453|-0.5144|4.95|4.95|6.1195|62156.4333||4.27|3.39
adr_usa_0459|BVXV|201509|10.3108|9.7576||0.558||2.1036|0.3385|1.7651||9.2927|-19.4629||||-0.5755||||1.2548|||0||1.3041|0.406|0.3385|0|||||||3.3774||0.0103|3.3774||135.0974|||0.0103|-0.0534|||-2.2473|||||0.2517|0.0349|0.0349|0.6116|3.54|3.54|1.3574|194275.0667||3.78|3.72
adr_usa_0459|BVXV|201512|9.4772|9.1072||0.5246||1.992|0.436|1.556||8.609|-20.4497||||-1.407||||1.4291|||0||1.1253|0.3601|0.2389|0|||||||3.3883|17|-0.31|3.3774||135.0974|||-0.31|0.0751|||-2.6277|||||0.2707|-0.844|-0.844|-0.0788|3.932|3.932|3.5224|6564.1667||3.79|3.6225
adr_usa_0459|BVXV|201603|9.0228|8.4193||0.5033||1.635|0.4155|1.2195||8.5097|-21.5442||||-1.3981||||1.4804|||0||0.701|0.6035|0.4155|0||||0.3142|||3.3774||-0.1025|3.3774||135.0974|||-0.1025|0|||-2.6096|||||0.1976|-0.4552|-0.4552|0.2712|3.73|3.73|4.1784|4465|-24.4444|3.8001|3.6
adr_usa_0459|BVXV|201606|8.2603|4.4432||0.4537||1.5977|0.2998|1.2978||7.776|-21.8442||||-1.4885||||1.5121|||0||1.1857|0.8283|0.2998|0|||4|0.5042|||3.3774||-0.21|3.3774||135.0974|||-0.21|0|||-1.9507|||||0.2622|-0.6861|-0.6864|-0.036|3.81|3.81|4.4486|12115.8667|-27.2157|3.58|3.88
adr_usa_0459|BVXV|201609|7.5672|4.5673||0.425||1.2134|0.2517|0.9616||7.4249|-23.0736||||-2.5479||||1.5984|||0||0.849|0.1941|0.2517|0|||5|-0.0183|||3.3774||-0.2106|3.3774||135.0974|||-0.2106|0|||-2.6059|||||0.2762|-0.6202|-0.6202|0.2933|3.68|3.68|7.9856|1813.2667|-5.1546|3.75|3.68
adr_usa_0459|BVXV|201612|6.816|4.6212||0.3763||1.1719|0.3585|0.8133||6.6796|-23.1726||||-2.5213||||1.5238|||0||0.5138|0.1992|0.1789|0|||4|-0.8251|||3.3774|14|-0.2093|3.3774||135.0974|||-0.2093|0|||-2.3994|||||0.3241|-0.6375|-0.6375|-0.5248|3.35|3.35|6.747|2642.7|-14.8016|5.05|6
adr_usa_0459|BVXV|201703|10.9693|7.7378||0.3573||3.3615|0.3521|3.0094||8.0968|-27.7408||||-5.7085||||2.8489|||0||0.3335|1.3716|0.3521|0|||8|0.2805|||4.062||-0.7514|3.3774||135.0974|||-0.7514|-2.926|||-5.1192|||||0.2936|-3.175|-3.175|-2.3786|5.6343|5.6343|14.4081|11373.4|51.7861|6.4499|7.4
adr_usa_0459|BVXV|201706|11.3075|10.1565||0.3537||5.7844|0.5313|5.2531||6.0217|-32.2387||||-12.7546||||4.629|||0||0.4502|0.8068|0.5313|0|||10|-0.1567|||4.3952||-0.7808|4.4899||179.5952|||-0.7808|-1.3649|||-7.6877|||||0.1587|-3.2549|-3.2549|-2.5324|8.5319|8.5319|29.742|29581.1667|130.5919|10.05|8.19
adr_usa_0459|BVXV|201709|23.1954|21.7847||0.3706||4.2628|0.8885|3.3743||19.4491|-31.4671||||-15.4893||||7.7167|||0||0.048|1.0707|0.8885|0|||10|1.2437|||5.0326||0.1125|6.5355||261.4196|||0.1125|-11.4274|||-6.701|||||0.5727|0.3665|0.3665|1.2695|7.11|7.11|36.3109|48449.4667|86.8594|7.27|5.85
adr_usa_0459|BVXV|201712|21.8317|20.6944||1.5974||7.3762|1.9955|5.3807||16.3081|-35.7799||||-3.7526||||1.7507|||0||0.1645|0.9199|1.8041|0|||9|1.9622|||6.5521|14|-0.5706|6.5355||261.4196|||-0.5706|0.186|||-9.5867|||||0.2996|-3.5233|-3.5233|3.8163|5.21|5.21|12.2652|16678.1|48.8571|7.26|6
adr_usa_0459|BVXV|201803|16.7358|15.8869||3.5774||8.5431|2.6521|5.8911||12.0213|-39.2697||||-3.6757||||2.1841|||0||0.0864|0.8489|2.6521|0|||3|3.7876|||6.5355||-0.5783|6.5355||261.4196|||-0.5783|-3.153|||-10.5184|||||0.2556|-4.1067|-4.1067|-0.4549|5.45|5.45|14.924|8372.9333|-3.271|6.39|6.4
adr_usa_0459|BVXV|201806|11.2738|10.1608||5.1431||12.0844|0.5755|11.5089||4.5733|-44.6383||||-3.3171||||3.561|||0||0.1639|1.113|0.5755|0|||3|3.7367|||6.5355||-1.1199|6.5355||261.4196|||-1.1199|3.153|||-14.4006|||||0.4046|-7.1371|-7.1371|1.4444|6.55|6.55|26.9206|6057.3|-23.2293|6.083|5.495
adr_usa_0459|BVXV|201809|15.4584|14.7046||6.7091||18.3868|0.7529|17.6339||4.0272|-45.8914||||-1.6458||||8.0742|||0||0.1914|0.7538|0.7529|0|||2|2.7585|||6.5355||-0.1102|6.5355||261.4196|||-0.1102|0|||-15.3871|||||0.4065|-0.62|-0.62|0.9843|5.65|5.65|32.4325|5756.4667|-19.0141|5.48|5.9
adr_usa_0459|BVXV|201812|20.4242|20.1677||7.5079||36.4249|5.7936|30.6313||-8.2961|-56.1166||||-1.2451||||7.1404|||0||0.092|0.1018|5.5076|0|||7|2.2387|||6.5355|21|-1.944|6.5355||261.4196|||-1.944|0|||-24.2253|||||0.3469|-12.3615|-12.3615|-5.5765|4.3999|4.3999|25.9206|5798.6|-20.9213|5.0473|5.07
adr_usa_0459|BVXV|201903|16.3823|15.8709||10.8309||35.8483|4.7448|31.1034||-8.4389|-58.0905||||-1.7924|||||||0||0.0505|0.5114|4.5583|0|||4|1.153|||6.5355||0.022|6.5355||261.4196|||0.022|0|||-19.9633|||||0.3933|0.1553|0.1553|2.1218|5.43|5.43|40.3985|5322.5667|2.0183|7.05|6.66
adr_usa_0459|BVXV|201906|9.8502|9.4979||11.2254||41.525|2.8035|38.7215||-20.3066|-72.2413||||-2.0669|||||||0||0.047|0.3523|2.6114|0|||7|1.0366|||6.5371||-2.0042|6.5439||261.7541|||-2.0042|0|||-26.0177|||||1.2577|-13.1915|-13.1915|-7.7104|5.75|5.75|46.2026|5069.9333|-12.2137|6.52|5.65
adr_usa_0459|BVXV|201909|22.1634|21.6212||11.9805||40.1607|0.8818|39.2788||-5.8711|-79.6846||||-4.7691|||||||0||0.0432|0.5422|0.6816|0|||8|1.331|||9.4475||-0.5677|10.0588||402.3516|||-0.5677||||-30.892|||||0.792|-5.4943|-5.4943|-0.1226|5.94|5.94|77.8535|6889.6667|5.4195|5.4|5.61
adr_usa_0459|BVXV|201912|21.1363|20.9467||12.174||52.2613|5.4801|46.7812||-18.8036|-92.594||||-6.6329|||||||0||0.2955|0.1009|4.9318|0|||5|1.2311|||10.8556|25|-1.1457|10.0588||402.3517|||-1.1457||||-30.8512|||||0.2764|-12.3207|-12.3207|-2.9911|9.29|9.29|108.2783|26472.9667|101.4563|11.25|8.5501
adr_usa_0459|BVXV|202003|||||||1.3372|40.4792||-17.1891|-90.8559||||-4.8373|||||||0||0.0665||0.9191||||10|1.7387|||10.2149||-0.1146|10.2553||410.214|||-0.1146||||-32.0656|||||0.2812|-1.0591|-1.0591|4.6874|7.7|7.7|78.9658|26916.5667|36.1905|11.2432|19
adr_usa_0459|BVXV|202006|11.9686|11.2523||12.6597||42.867|1.8453|41.0217||-17.98|-106.2772||||-17.5368|||||||0||0.0769|0.7163|1.649|0|||10|3.6065|||10.8375||-1.1387|11.5206||460.8226|||-1.1387||||-30.8244|||||1.1783|-11.9503|-11.9503|-7.3707|22.75|22.75|286.2779|83603.6|294.9653|37.92|37.49
adr_usa_0459|BVXV|202009|||||||||||||||-28.8721|||||||0||0.3358||||||10|3.2739||||||||||||||||||||||||38.79|38.79|471.3205|69996.9333|551.2542|5.2|